Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FGER4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,584
Award facts
- Contract value 100% obligated
- $16,584.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,584.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on January 6, 2026, with an ultimate completion date of January 28, 2026, represents a competitive award without set-aside designation. The contract was funded by the Defense Logistics Agency's Medical Supply Chain division and will be fulfilled at the contractor's location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.99 billion acquisition strategy supporting the Department of Defense's pharmaceutical supply needs globally. The broader PPV-G GEN V program encompasses multiple regional prime vendor contractors authorized to supply a comprehensive range of pharmaceuticals, biologics, and medical consumables to military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to serve as a critical pharmaceutical supplier for DoD healthcare operations, with this delivery order exemplifying the routine fulfillment of specialized pharmaceutical requirements essential to military medical readiness.
Quick answers
Who was awarded contract SPE2DR26FGER4?
SPE2DR26FGER4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FGER4 worth?
The government has obligated $16,584 on SPE2DR26FGER4.
Is contract SPE2DR26FGER4 an order under another contract?
Yes. SPE2DR26FGER4 is a delivery order under SPE2DR25D9312, an indefinite delivery contract.
Was contract SPE2DR26FGER4 competed?
The extent of competition for SPE2DR26FGER4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award